Terumo Corporation (TYO: 4543)
Japan
· Delayed Price · Currency is JPY
2,925.50
+10.00 (0.34%)
Jan 20, 2025, 3:30 PM JST
Terumo Revenue
Terumo had revenue of 250.49B JPY in the quarter ending September 30, 2024, with 9.57% growth. This brings the company's revenue in the last twelve months to 986.67B, up 14.63% year-over-year. In the fiscal year ending March 31, 2024, Terumo had annual revenue of 921.86B with 12.39% growth.
Revenue (ttm)
986.67B
Revenue Growth
+14.63%
P/S Ratio
4.41
Revenue / Employee
32.25M
Employees
30,591
Market Cap
4,315.57B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 921.86B | 101.65B | 12.39% |
Mar 31, 2023 | 820.21B | 116.91B | 16.62% |
Mar 31, 2022 | 703.30B | 89.46B | 14.57% |
Mar 31, 2021 | 613.84B | -15.06B | -2.39% |
Mar 31, 2020 | 628.90B | 29.42B | 4.91% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,142.35B |
Daiichi Sankyo Company | 1,758.07B |
HOYA Corporation | 812.74B |
Takeda Pharmaceutical Company | 4,546.08B |
Otsuka Holdings | 2,269.56B |
Astellas Pharma | 1,772.16B |
Olympus | 973.60B |
Shionogi & | 418.51B |
Terumo News
- 11 days ago - Terumo's Improving Growth Outlook Is Worth More Attention - Seeking Alpha
- 2 months ago - Terumo Corporation (TRUMF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Q2 2025 Terumo Corp Earnings Presentation Transcript - GuruFocus
- 3 months ago - Terumo Is a Great Choice for 'Trend' Investors, Here's Why - Benzinga
- 5 months ago - IceCure Medical Reports 20% Growth in ProSense® System and Probe Sales for the First Half of 2024; Reflects Continued Adoption in the U.S. and Other Global Markets - Benzinga
- 5 months ago - Q1 2025 Terumo Corp Earnings Presentation Transcript - GuruFocus
- 8 months ago - Terumo Corporation (TRUMY) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Terumo Corporation (TRUMF) Q3 2024 Earnings Call Transcript - Seeking Alpha